Unveiling the Unobservable: Causal Inference on Multiple Derived Outcomes
揭示不可观测量:多个衍生结果的因果推断AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要明确讨论处理分配可忽略性、因果参数识别及逆倾向得分加权,直接属于因果推断方向。
揭示不可观测量:多个衍生结果的因果推断AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
In many applications, the interest is in treatment effects on random quantities of subjects, where those random quantities are not directly observable but can be estimated based on data from each subject. In this article, we propose a general framework for conducting causal inference in a hierarchical data generation setting. The identifiability of causal parameters of interest is shown under a condition on the biasedness of subject level estimates and an ignorability condition on the treatment assignment. Estimation of the treatment effects is constructed by inverse propensity score weighting on the estimated subject level parameters. A multiple testing procedure able to control the false discovery proportion is proposed to identify the nonzero treatment effects. Theoretical results are developed to investigate the proposed procedure, and numerical simulations are carried out to evaluate its empirical performance. A case study of medication effects on brain functional connectivity of patients with Autism spectrum disorder (ASD) using fMRI data is conducted to demonstrate the utility of the proposed method. Supplementary materials for this article are available online.